Skip to main content
Equibles

Squarepoint Ops LLC

Position in IMVT — Immunovant, Inc.

CIK 1642575 NEW YORK, NY
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,996,439
+$1,637,735 QoQ
Shares Held
77,769
-8.4% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 226 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. IMVT ranks #63 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in IMVT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,996,439 77,769
2025-06-30 $1,358,704 84,919
2025-03-31 $178,163 10,425
2024-06-30 $1,301,203 49,288
2024-03-31 $1,508,004 46,673
2023-09-30 $559,994 14,587
2023-03-31 $1,456,311 93,895
2022-12-31 $620,398 34,952
2022-03-31 $154,483 28,037
2021-12-31 $578,644 67,916
2021-09-30 $680,253 78,280
2021-06-30 $374,241 35,406
2021-03-31 $751,393 46,845
2020-12-31 $1,034,055 22,387
2020-09-30 $619,695 17,610